HER2 Negative Breast Cancer
Symptoms, Doctors, Treatments, Advances & More

HER2 Negative Breast Cancer Overview

Save information for later
Sign Up

Learn About HER2 Negative Breast Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top HER2 Negative Breast Cancer Local Doctors?
Elite in HER2 Negative Breast Cancer
Elite in HER2 Negative Breast Cancer

Brigham And Women's Hospital, Division Of Breast Surgery

75 Francis Street, 
Boston, MA 
Languages Spoken:
English

Dr. Lin is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer, including a particular focus on the challenge of breast cancer brain metastases. She has led multiple clinical trials which have led to new treatment options for patients with breast cancer that has metastasized to the brain. Dr. Lin received her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women's Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber. In 2005, she joined the staff of Brigham and Women's and Dana-Farber, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Dr. Lin is rated as an Elite provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Brain Tumor, and Inflammatory Breast Cancer. Dr. Lin is board certified in Medical Oncology.

Elite in HER2 Negative Breast Cancer
Elite in HER2 Negative Breast Cancer
Ernst Grube Str. 40, 
Halle, NI, DE 

Christoph Thomssen practices practicing medicine in Halle, Germany. Mr. Thomssen is rated as an Elite expert by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses HER2 Negative Breast Cancer, Breast Cancer, BRCA Positive Breast Cancer, Mastectomy, and Hormone Replacement Therapy (HRT).

 
 
 
 
Learn about our expert tiers
Learn More
Elite in HER2 Negative Breast Cancer
Elite in HER2 Negative Breast Cancer

UZ Leuven, Campus Gasthuisberg

Leuven, VLG, BE 

Patrick Neven practices practicing medicine in Leuven, Belgium. Mr. Neven is rated as an Elite expert by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Mastectomy, and Oophorectomy.

What are the latest HER2 Negative Breast Cancer Clinical Trials?
SIgnatera-Guided Initiation of Adjuvant CDK4/6 Inhibitor in Intermediate Risk HR+ HER2- Breast Cancer

Summary: The purpose of this study is to evaluate the efficacy and safety of ctDNA-guided initiation of CDK4/6 inhibitor therapy using the Signatera™ Designed on Genome test (referred to as Signatera Genome) in participants with intermediate-risk HR+/HER2- early-stage breast cancer. Based on ctDNA test results, participants will either start CDK4/6 inhibitor therapy in addition to hormone therapy or contin...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Study of Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

Summary: This is an open label, multicenter, single arm phase II study to evaluate the efficacy and safety of ribociclib and ET in patients with locoregional recurrence of HR-positive, HER2-negative breast cancer.